These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 37171467)
1. Patient-reported outcomes for older adults on CamAPS FX closed loop system. Schneider-Utaka AK; Hanes S; Boughton CK; Hartnell S; Thabit H; Mubita WM; Draxlbauer K; Poettler T; Hayes J; Wilinska ME; Mader JK; Narendran P; Leelarathna L; Evans ML; Hovorka R; Hood KK Diabet Med; 2023 Sep; 40(9):e15126. PubMed ID: 37171467 [TBL] [Abstract][Full Text] [Related]
2. Lived experience of CamAPS FX closed loop system in youth with type 1 diabetes and their parents. Hood KK; Garcia-Willingham N; Hanes S; Tanenbaum ML; Ware J; Boughton CK; Allen JM; Wilinska ME; Tauschmann M; Denvir L; Thankamony A; Campbell F; Wadwa RP; Buckingham BA; Davis N; DiMeglio LA; Mauras N; Besser REJ; Ghatak A; Weinzimer SA; Fox DS; Kanapka L; Kollman C; Sibayan J; Beck RW; Hovorka R; Diabetes Obes Metab; 2022 Dec; 24(12):2309-2318. PubMed ID: 35837984 [TBL] [Abstract][Full Text] [Related]
3. Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study. Boughton CK; Hartnell S; Thabit H; Mubita WM; Draxlbauer K; Poettler T; Wilinska ME; Hood KK; Mader JK; Narendran P; Leelarathna L; Evans ML; Hovorka R Lancet Healthy Longev; 2022 Mar; 3(3):e135-e142. PubMed ID: 35359882 [TBL] [Abstract][Full Text] [Related]
4. Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes. Thabit H; Boughton C; Mubita W; Rubio J; Mader JK; Narendran P; Evans M; Leelarathna L; Wilinska ME; Fullwood C; Gregory AM; Hovorka R; Rutter MK Diabetes Obes Metab; 2023 Mar; 25(3):889-893. PubMed ID: 36335565 [No Abstract] [Full Text] [Related]
5. Lived experience of older adults with type 1 diabetes using closed-loop automated insulin delivery in a randomised trial. Kubilay E; Trawley S; Ward GM; Fourlanos S; Grills CA; Lee MH; MacIsaac RJ; O'Neal DN; O'Regan NA; Sundararajan V; Vogrin S; Colman PG; McAuley SA Diabet Med; 2023 Apr; 40(4):e15020. PubMed ID: 36468784 [TBL] [Abstract][Full Text] [Related]
6. Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study. Boughton CK; Hartnell S; Thabit H; Poettler T; Herzig D; Wilinska ME; Ashcroft NL; Sibayan J; Cohen N; Calhoun P; Bally L; Mader JK; Evans M; Leelarathna L; Hovorka R Diabetes Obes Metab; 2021 Jun; 23(6):1389-1396. PubMed ID: 33606901 [TBL] [Abstract][Full Text] [Related]
7. Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes. Thabit H; Elleri D; Leelarathna L; Allen JM; Lubina-Solomon A; Stadler M; Walkinshaw E; Iqbal A; Choudhary P; Wilinska ME; Barnard KD; Heller SR; Amiel SA; Evans ML; Dunger DB; Hovorka R Diabetes Obes Metab; 2015 May; 17(5):452-8. PubMed ID: 25492378 [TBL] [Abstract][Full Text] [Related]
15. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Cobry EC; Kanapka LG; Cengiz E; Carria L; Ekhlaspour L; Buckingham BA; Hood KK; Hsu LJ; Messer LH; Schoelwer MJ; Emory E; Ruedy KJ; Beck RW; Wadwa RP; Gonder-Frederick L; Diabetes Technol Ther; 2021 Jun; 23(6):401-409. PubMed ID: 33404325 [No Abstract] [Full Text] [Related]
16. Hybrid closed-loop therapy: Where are we in 2021? Leelarathna L; Choudhary P; Wilmot EG; Lumb A; Street T; Kar P; Ng SM Diabetes Obes Metab; 2021 Mar; 23(3):655-660. PubMed ID: 33269551 [TBL] [Abstract][Full Text] [Related]
17. Behavioral Patterns and Associations with Glucose Control During 12-Week Randomized Free-Living Clinical Trial of Day and Night Hybrid Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes. Emami A; Willinska ME; Thabit H; Leelarathna L; Hartnell S; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Pieber TR; Arnolds S; Evans ML; Hovorka R Diabetes Technol Ther; 2017 Jul; 19(7):433-437. PubMed ID: 28463010 [TBL] [Abstract][Full Text] [Related]
18. Real world use of hybrid-closed loop in children and young people with type 1 diabetes mellitus-a National Health Service pilot initiative in England. Ng SM; Wright NP; Yardley D; Campbell F; Randell T; Trevelyan N; Ghatak A; Hindmarsh PC Diabet Med; 2023 Feb; 40(2):e15015. PubMed ID: 36424877 [TBL] [Abstract][Full Text] [Related]
19. Patient-Reported Outcomes in a Randomized Trial of Closed-Loop Control: The Pivotal International Diabetes Closed-Loop Trial. Kudva YC; Laffel LM; Brown SA; Raghinaru D; Pinsker JE; Ekhlaspour L; Levy CJ; Messer LH; Kovatchev BP; Lum JW; Beck RW; Gonder-Frederick L; Diabetes Technol Ther; 2021 Oct; 23(10):673-683. PubMed ID: 34115959 [No Abstract] [Full Text] [Related]
20. Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review. Speight J; Choudhary P; Wilmot EG; Hendrieckx C; Forde H; Cheung WY; Crabtree T; Millar B; Traviss-Turner G; Hill A; Ajjan RA Diabet Med; 2023 Jan; 40(1):e14944. PubMed ID: 36004676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]